Dashboard
Manage Tickers

HOWLWerewolf Therapeutics, Inc.

Nasdaq werewolftx.com


$ 2.36 $ -0.09 (-3.69 %)    

Monday, 01-Jul-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 481.74 $ 2.81 (0.59 %)
DIA $ 391.56 $ 0.33 (0.08 %)
SPY $ 545.33 $ 1.12 (0.21 %)
TLT $ 90.13 $ -1.58 (-1.73 %)
GLD $ 215.59 $ 0.56 (0.26 %)
$ 2.35
$ 2.43
$ 2.35 x 400
$ 2.37 x 400
$ 2.17 - $ 2.50
$ 1.57 - $ 8.19
432,752
na
97.78M
$ 0.94
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 06-10-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jmp-securities-reiterates-market-outperform-on-werewolf-therapeutics-maintains-12-price-target
JMP Securities Reiterates Market Outperfor...
06/26/2024 16:05:54

JMP Securities analyst Reni Benjamin reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform and maintains $...

where-werewolf-therapeutics-stands-with-analysts
Where Werewolf Therapeutics Stands With An...
06/26/2024 12:01:27

hc-wainwright--co-reiterates-buy-on-werewolf-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Were...
06/26/2024 11:08:35

HC Wainwright & Co. analyst Andres Maldonado reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and maintains $15...

werewolf-therapeutics-announced-initial-results-from-phase-1-trial-of-wtx-330-as-monotherapy-for-immunotherapy-insensitive-or-resistant-locally-advanced-or-metastatic-solid-tumors-or-non-hodgkin-lymphoma-additional-results-expected-in-q4-of-2024
Werewolf Therapeutics Announced Initial Re...
06/25/2024 11:11:59

jmp-securities-reiterates-market-outperform-on-werewolf-therapeutics-maintains-12-price-target
JMP Securities Reiterates Market Outperfor...
06/04/2024 12:23:15

JMP Securities analyst Reni Benjamin reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform and maintains $...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/03/2024 16:31:06

hc-wainwright--co-reiterates-buy-on-werewolf-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Were...
06/03/2024 14:14:04

HC Wainwright & Co. analyst Andres Maldonado reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and maintains $15...

critical-insights-from-werewolf-therapeutics-analyst-ratings-what-you-need-to-know
Critical Insights From Werewolf Therapeuti...
05/24/2024 13:00:40

hc-wainwright--co-reiterates-buy-on-werewolf-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Were...
05/24/2024 10:53:04

HC Wainwright & Co. analyst Andres Maldonado reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and maintains $15...

the-analyst-verdict-werewolf-therapeutics-in-the-eyes-of-4-experts
The Analyst Verdict: Werewolf Therapeutics...
05/06/2024 15:00:57

jmp-securities-reiterates-market-outperform-on-werewolf-therapeutics-maintains-12-price-target
JMP Securities Reiterates Market Outperfor...
05/06/2024 14:57:04

JMP Securities analyst Reni Benjamin reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform and maintains $...

hc-wainwright--co-reiterates-buy-on-werewolf-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Were...
05/06/2024 10:51:57

HC Wainwright & Co. analyst Andres Maldonado reiterates Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and maintains $15...

werewolf-therapeutics-q1-eps-039-misses-035-estimate-sales-74200-miss-182m-estimate
Werewolf Therapeutics Q1 EPS $(0.39) Misse...
05/03/2024 11:19:18

Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate ...

werewolf-therapeutics-announces-wtx-124-clinical-abstract-accepted-for-presentation-at-the-2024-asco-annual-meeting
Werewolf Therapeutics Announces WTX-124 Cl...
04/24/2024 14:05:50

Company to present an update of its ongoing monotherapy and combination Phase 1/1b study of WTX-124 in advanced or metastatic s...

werewolf-therapeutics-presents-first-preclinical-data-highlighting-il-10-indukine-molecules-as-potential-therapy-for-inflammatory-bowel-disease-at-aai-annual-meeting
Werewolf Therapeutics Presents First Precl...
04/23/2024 12:14:16

First Data Demonstrating Application of PREDATOR™ Platform in Immune-Mediated Diseases

werewolf-therapeutics-presents-preclinical-results-demonstrating-anti-tumor-effects-of-pro-inflammatory-cytokine-therapeutics-wtx-518-and-wtx-712-at-aacr-2024-annual-meeting
Werewolf Therapeutics Presents Preclinical...
04/05/2024 20:32:25

 WTX-518, a conditionally activated IL-18 INDUKINETM molecule that resists suppression by IL-18BP, led to complete tumor regres...

jmp-securities-initiates-coverage-on-werewolf-therapeutics-with-market-outperform-rating-announces-price-target-of-12
JMP Securities Initiates Coverage On Werew...
04/03/2024 08:47:37

JMP Securities analyst Reni Benjamin initiates coverage on Werewolf Therapeutics (NASDAQ:HOWL) with a Market Outperform rati...

hc-wainwright--co-maintains-buy-on-werewolf-therapeutics-maintains-15-price-target
HC Wainwright & Co. Maintains Buy on Werew...
03/07/2024 16:58:38

HC Wainwright & Co. analyst Andres Maldonado maintains Werewolf Therapeutics (NASDAQ:HOWL) with a Buy and maintains $15 ...

recap-werewolf-therapeutics-q4-earnings
Recap: Werewolf Therapeutics Q4 Earnings
03/07/2024 14:00:07

werewolf-therapeutics-q4-eps-033-beats-043-estimate-sales-150m-miss-194m-estimate
Werewolf Therapeutics Q4 EPS $(0.33) Beats...
03/07/2024 12:11:57

Werewolf Therapeutics (NASDAQ:HOWL) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)